Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

CGEN

COMPUGEN LTD

Tremor tracks 2 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • CGENCompugen Ltd
    10Calm

    COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

    FinishedPhase 1/248 patientsMain results: May 15, 2024
  • CGENCompugen Ltd
    0Calm

    A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

    Running, no new patientsPhase 1/260 patientsMain results: Mar 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

1 sale (0 not pre-planned) · 0 purchases

  • Levine ZuritSVP, Business Development · Jul 9, 2026Sold 1,875 sharesabout $5 thousand · pre-planned

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • None in the last 12 months.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.